ArticleAntibiotics (Basel, Switzerland)2026
Distribution and Antibiotic Resistance of
Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to retrospectively analyze the demographic characteristics of patients, clinical specimen types, and antibiotic susceptibility patterns of MATERIALS AND
methodsA total of 443
resultsThe number of isolates showed a fluctuating trend over the years, with the highest number recorded in 2022 (n = 94). The majority of isolates were obtained from intensive care units (71.3%), followed by inpatient wards (21.9%). Among clinical specimens, blood (42.7%) and tracheal aspirates (18.5%) were the most common. Significant temporal changes were observed in TMP-SMX susceptibility patterns. Fully susceptible isolates predominated in the early years, whereas intermediate susceptibility became increasingly common after 2021, while resistance rates remained relatively low throughout the study period.
conclusion
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.